Cardiovascular health — blood pressure, cholesterol, heart function, and circulation.
Compounds with published trial evidence for this condition, ranked by strength of evidence. Numbers come from the trial reports themselves — see each study via its PMID.
| Compound | Evidence strength | What trials suggest | Study |
|---|---|---|---|
| Coq10 | 1 systematic review/meta-analysis outcome | Results for adverse events risk were inconclusive with RR 0.70 vs control in 568 participants.3/1 outcomes showed benefit | PMID 35608922 |
| Taurine | 1 randomised trial outcome | Taurine attenuated delayed arterial stiffness increase vs placebo in 29 men over 14 days.2/1 outcomes showed benefit | PMID 27163699 |
Audited published findings per compound. Dark green = benefit findings; full bar = all findings. Drill into a pair for the breakdown.
These compounds appear in related research or traditional use. Their position is not a recommendation or ranking.
Be the first to share what has helped with heart health.
Open the original papers, check their methods, and discuss what is relevant with a qualified professional.
Randomized Controlled Trial · matched via Heart Health · PubMed record (CORPUS-A)
PMID 42514394 ↗02Taurine supplementation as a therapeutic strategy for cellular senescence and chronic inflammation in long COVID: a systematic review and meta-analysisWang K, et al. · BMC infectious diseases · 2026Systematic Review · matched via Heart Health · PubMed record (CORPUS-A)
PMID 41803812 ↗03Energy Drinks as the Legal Cocaine? A Comparative Review of Cardiac Physiopathological and Histopathological PatternsGhamlouch A, et al. · Cardiovascular toxicology · 2025Systematic Review · matched via Heart Health · PubMed record (CORPUS-A)
PMID 41266869 ↗04Effect of Taurine Combined With Creatine on Repeated Sprinting Ability After Exhaustive Exercise Under Hot and Humid ConditionsYu P, et al. · Sports health · 2025Randomized Controlled Trial · matched via Heart Health · PubMed record (CORPUS-A)
PMID 39972259 ↗05Omega-3 and cardiovascular disease: A updated meta-analysisBernasconi AA et al. · Mayo Clin Proc · 2024EPA/DHA supplementation reduced cardiovascular events and mortality in pooled analysis.
PMID 33039606 ↗06Selenoprotein P increases upon selenium and coenzyme Q(10) supplementation and is associated with telomere length, quality of life and reduced inflammation and mortalityRandomized Controlled Trial · matched via Heart Health · PubMed record (CORPUS-A)
Outcome summaries extracted from the linked papers' curated records. Educational, not medical advice.
Reduced in pooled analysis (EPA/DHA)
Adults in cardiovascular prevention trials · Meta-analysis · PMID 33039606 ↗Strong evidenceReduced02Survival and hospitalisations in heart failure — ImprovedImproved survival; fewer hospitalisations
Chronic heart failure patients · Meta-analysis · PMID 25039165 ↗Strong evidenceImprovedFigures are reported as published; study designs and populations vary. Works for Us does not interpret results or provide medical advice.